Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Cara Therapeutics, Inc. | Director | Common Stock | 411K | $308K | $0.75 | Jun 4, 2024 | Direct |
Cara Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 390K | Jun 4, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CARA | Cara Therapeutics, Inc. | Jun 4, 2024 | 2 | $0 | 4 | Jun 6, 2024 | Director |
CARA | Cara Therapeutics, Inc. | Jun 1, 2023 | 2 | $0 | 4 | Jun 5, 2023 | Director |
CARA | Cara Therapeutics, Inc. | Sep 14, 2022 | 1 | -$111K | 4 | Sep 16, 2022 | Director |
CARA | Cara Therapeutics, Inc. | Jun 2, 2022 | 3 | $0 | 4 | Jun 6, 2022 | Director |
CARA | Cara Therapeutics, Inc. | Jun 3, 2021 | 3 | -$113K | 4 | Jun 7, 2021 | Director |